| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.8 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.8 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |